Join the Duke-Margolis Center for Health Policy for an in-depth discussion on the rapid growth of individualized and precision therapies — and the implications for patients, payers, and policy. This event will bring together leaders from academia, industry, and government to explore evolving approaches to gene and cell therapies, regulatory and reimbursement frameworks, and strategies for equitable access to transformative treatments.